This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vassbotn, F S Articles by Ostman, A Search for Related Content PubMed PubMed Citation Articles by Vassbotn, F S Articles by Ostman, A

 Previous Article  |  Next Article 

Mol Cell Biol. 1993 July; 13(7): 4066-4076

Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.

Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.

ABSTRACT

A non-receptor-binding mutant of the platelet-derived growth factor (PDGF) A chain, PDGF-0, was generated by exchanging 7 amino acids in the sequence. The mutant chains formed dimers that were similar to wild-type PDGF-AA with regard to stability and rate of processing to the mature 30-kDa secreted forms. Moreover, the mutant chains formed disulfide-bonded heterodimers with the PDGF B chain in NIH 3T3 cells heterodimer underwent the same processing and secretion as PDGF-AB. Transfection of c-sis-expressing 3T3 cells with PDGF-0 significantly inhibited the transformed phenotype of these cells, as determined by the following criteria. (i) Compared with PDGF-0-negative clones, PDGF-0-producing clones showed a reverted morphology. (ii) Clones producing PDGF-0 grew more slowly than PDGF-0-negative clones, with a fivefold difference in cell number after 14 days in culture. (iii) The expression of PDGF-0 completely inhibited the ability of the c-sis-expressing 3T3 cells to form colonies in soft agar; this inhibition was overcome by the addition of recombinant PDGF-BB to the culture medium, showing that the lack of colony formation of these cells was not due to a general unresponsiveness to PDGF. The specific expression of a PDGF-0/PDGF wild-type heterodimer in COS cells revealed that the affinity of the mutant heterodimer for the PDGF alpha receptor was decreased by approximately 50-fold compared with that of PDGF-AA. Thus, we show that a non-receptor-binding PDGF A-chain mutant neutralizes in a trans-dominant manner the autocrine transforming potential of the c-sis/PDGF B chain by forming low-affinity heterodimers with wild-type PDGF chains. This method of specifically antagonizing the effect of PDGF may be useful in investigations of the role of PDGF in normal and pathological conditions.

This article has been cited by other articles:

• Ma, D., Nutt, C. L., Shanehsaz, P., Peng, X., Louis, D. N., Kaetzel, D. M. (2005). Autocrine Platelet-Derived Growth Factor-Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Altered Genotype and Patient Survival in Human Brain Tumors. Cancer Res. 65: 5523-5534 [Abstract] [Full Text]  
• Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., Giese, N. A. (2002). Platelet-derived Growth Factor (PDGF) Autocrine Signaling Regulates Survival and Mitogenic Pathways in Glioblastoma Cells: Evidence That the Novel PDGF-C and PDGF-D Ligands May Play a Role in the Development of Brain Tumors. Cancer Res. 62: 3729-3735 [Abstract] [Full Text]  
• Kilic, T., Alberta, J. A., Zdunek, P. R., Acar, M., Iannarelli, P., O’Reilly, T., Buchdunger, E., Black, P. M., Stiles, C. D. (2000). Intracranial Inhibition of Platelet-derived Growth Factor-mediated Glioblastoma Cell Growth by an Orally Active Kinase Inhibitor of the 2-Phenylaminopyrimidine Class. Cancer Res. 60: 5143-5150 [Abstract] [Full Text]  
• Stacker, S. A., Vitali, A., Caesar, C., Domagala, T., Groenen, L. C., Nice, E., Achen, M. G., Wilks, A. F. (1999). A Mutant Form of Vascular Endothelial Growth Factor (VEGF) That Lacks VEGF Receptor-2 Activation Retains the Ability to Induce Vascular Permeability. J. Biol. Chem. 274: 34884-34892 [Abstract] [Full Text]  
• Siemeister, G., Schirner, M., Reusch, P., Barleon, B., Marme, D., Martiny-Baron, G. (1998). An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA 95: 4625-4629 [Abstract] [Full Text]  
• Waltenberger, J. (1997). Modulation of Growth Factor Action : Implications for the Treatment of Cardiovascular Diseases. Circulation 96: 4083-4094 [Abstract] [Full Text]  
• Omura, T., Heldin, C.-H., Ostman, A. (1997). Immunoglobulin-like Domain 4-mediated Receptor-Receptor Interactions Contribute to Platelet-derived Growth Factor-induced Receptor Dimerization. J. Biol. Chem. 272: 12676-12682 [Abstract] [Full Text]  
• DeMali, K. A., Whiteford, C. C., Ulug, E. T., Kazlauskas, A. (1997). Platelet-derived Growth Factor-dependent Cellular Transformation Requires Either Phospholipase Cgamma or Phosphatidylinositol 3Kinase. J. Biol. Chem. 272: 9011-9018 [Abstract] [Full Text]